This is a competing renewal of a postdoctoral training program entitled Training in Investigative Infectious Diseases based in the Section of Infectious Diseases, Department of Internal Medicine at the Yale School of Medicine.
The aims of this training program are to: (a) develop the next generation of Infectious Disease investigators trained in translational research (b) develop new prevention and therapeutic strategies for infectious diseases of national and international significance and (c) advance the principles associated with high quality research including adherence to ethical principles. The program is designed for physicians with an MD, MD-PhD, DO or equivalent degree. Most trainees will be Fellows in Infectious Diseases, but selected M.D.s or MD-PhDs with clinical training in other fields will also be eligible to participate. The highly accomplished training faculty has four broadly defined areas of research: (1) Innate Immunity and Microbes, (2) Vector-borne Diseases, (3) Molecular and Human Infectious Disease Pathogenesis, and (4) Clinical and Epidemiologic Infectious Disease Research. Detailed plans for trainee admission to the program, mentor and mentorship committee selection, and evaluation of trainee progress are in place. In addition to outstanding research training, Yale has opportunities for study toward advanced degrees such as a Masters in Health Science or PhD in Investigative Medicine that are open to physicians in the T32 training program. Extensive didactic training is also available through the Graduate School of Arts and Sciences, School of Public Health and the Yale National Clinician Scholars Program. This combination of outstanding research opportunities, didactic coursework and seminar series, and career development training in grant writing and presentation skills has resulted in a high level of programmatic success in training physician-investigators at Yale who choose research careers in academia or industry. At the same time, the T32 Infectious Diseases training program at Yale continues to evolve and improve, with the addition of new training faculty with interests in global health, enhanced recruitment of MD-PhD physician-scientists, a plan to enhance underrepresented minority fellowship recruitment that includes a common ?second look? visit for minority applicants to fellowships throughout the entire Department of Internal Medicine, and improvements in career development activities designed to facilitate mentor selection, increase interactions with the diverse and accomplished training faculty and provide training in leadership and negotiation skills. We believe these changes will further enhance the ability of our trainees to contribute high impact, new knowledge in Infectious Disease.

Public Health Relevance

The goals of the Infectious Diseases Training Program at Yale are to train and develop the next generation of physician-investigators in infectious diseases research and the responsible conduct of research, and through this training program contribute to the development of new prevention and therapeutic measures for infectious diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
2T32AI007517-16
Application #
9151021
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Robbins, Christiane M
Project Start
1997-07-01
Project End
2021-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
16
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Datta, Rupak; Advani, Sonali; Rink, Andrea et al. (2018) Frequency of Infection during Fever Episodes among Long-Term Care Residents. J Gerontol Geriatr Res 7:
Datta, Rupak; McManus, Dayna; Topal, Jeffrey et al. (2018) Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases. Open Forum Infect Dis 5:ofx277
Rojas, Laura J; Salim, Madiha; Cober, Eric et al. (2017) Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality. Clin Infect Dis 64:711-718
Zielinski, Mark R; Gerashchenko, Dmitry; Karpova, Svetlana A et al. (2017) The NLRP3 inflammasome modulates sleep and NREM sleep delta power induced by spontaneous wakefulness, sleep deprivation and lipopolysaccharide. Brain Behav Immun 62:137-150
van Duin, David (2017) Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know. Virulence 8:379-382
Lindquist, Lee A; Miller, Rachel K; Saltsman, Wayne S et al. (2017) SGIM-AMDA-AGS Consensus Best Practice Recommendations for Transitioning Patients' Healthcare from Skilled Nursing Facilities to the Community. J Gen Intern Med 32:199-203
Muthulingam, Dharushana (2017) Health Insurance and the Promise of Incrementalism. J Womens Health (Larchmt) 26:1263-1264
Gonzalo-Gil, Elena; Ikediobi, Uchenna; Sutton, Richard E (2017) Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers. Yale J Biol Med 90:245-259
Nance, Robin M; Delaney, J A Chris; Golin, Carol E et al. (2017) Co-calibration of two self-reported measures of adherence to antiretroviral therapy. AIDS Care 29:464-468
Nathavitharana, Ruvandhi R; Cudahy, Patrick G T; Schumacher, Samuel G et al. (2017) Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J 49:

Showing the most recent 10 out of 65 publications